Hypothalamic/Pituitary Hormones Flashcards
What is the MOA of somatotropin?
Somatropin is a direct agonist of the growth hormone receptor stimulating gene expression e.g. IGF1
Somatotropin: indications?
HRT for children w GH deficiency Other conditions of small stature Prader-willi syndrome Turner’s syndrome Noonan’s syndrome Chronic renal insufficiency Idiopathic short stature
Somatotropin: adverse effects?
Children:
Idiopathic intracranial HTN
Increased intraocular pressure
Development of insulin resistance
Adults: Peripheral edema Arthralgias Carpal tunnel Parathesis Worsening glucose intolerance Acute pancreatitis
Somatotropin: contra-indications?
Contraindications: Active malignancy Uncontrolled diabetes Proliferative retinopathy Children with closed epiphyses Prader-willi with severe obesity and/or respiratory obstruction
Mescarmin: MOA?
Recombinant IGF1
Is a downstream effector of GH-bypasses GHR defects and/or anti-GH Abs
Activates the IGF1R
Mescarmin: indications?
Children with impaired growth non-responsive to GH
e.g. mutations in GHR or downstream signaling pathway, neutralizing antibodies to GH, or IGF-1 gene defects (v. rare)
Mescarmin: adverse effects?
Hypoglycemia
Intracranial hypertension
Mescarmin: contraindications?
Active malignancy
Children with closed bone epiphyses
Name two somatostatin analogues
Octreotide
Lanreotide
Octreotide/Lanreotide: MOA?
Octreotide/Lanreotide are somatostatin receptors agonists
Stimulate pathways that inhibit production of GH
Octreotide/lanreotide: indications?
GH excess
Gigantism
Acromegaly
Other clinical uses Esophageal varices Carcinoid syndrome Gastrinoma glucagonoma
Octreotide/lanreotide: adverse effects?
Nausea/Diarrhea (~50%)
Gallstones (~25%)
Suppresses TSH (monitor for hypothyroidism
low risk- typically only transient effect)
Bradycardia & cardiac arrhythmias
Pegvisomant: MOA?
Direct antagonist of the growth hormone receptor
Pegvisomant: indications?
GH excess
Gigantism
Acromegaly
Name two dopamine agonists
Cabergoline
Bromocriptine
Bromocriptine/Cabergoline: MOA?
Direct agonists of D2 dopamine receptors
Bromocriptine/Cabergoline: indications?
Hyperprolactinemia
Other uses;
At high doses- treatment of acromegaly/gigantism
Bromocriptine/Cabergoline: adverse effects?
Nausea/headache
Orthostatic hypertension
Psychiatric symptoms
Name 5 gonadotropin releasing hormone agonists
Leuprolide Goserlin Buserlin Triptorelin Naferelin
What is the MOA of Leuprolide/Goserlin/Buserlin/Triptorelin/Naferelin?
Sustained activation of GnRH receptor inhibits
release of gonadotropins